Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active Not Recruiting
NCT06331312Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +17 more
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High RiskRecruiting
NCT07613294Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Atherosclerosis · Cardiovascular Diseases · Lipoprotein(a)
United States, Australia, Czechia, Hungary, Netherlands +2 more
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )Recruiting
NCT07101328Phase 1Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Lymphoma, Non-Hodgkin · B-cell Lymphoma · Lymphoma, Large B-Cell, Diffuse · Lymphoma, Follicular
United States, Australia, Canada, Denmark, France +7 more
MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)Not Yet Recruiting
NCT07780344NAUpdated Aug 21, 2026
Sponsor: University of Nottingham
Cystic Fibrosis (CF)
United Kingdom
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This MedicineActive Not Recruiting
NCT05846230Phase 2Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +17 more
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting
NCT06897475Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Type 2 Diabetes
United States, Canada, Germany, Poland, Puerto Rico +1 more
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).Recruiting
NCT05947851Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Leukemia, Lymphocytic, Chronic, B-Cell · Leukemia, Chronic Lymphocytic · Small-Cell Lymphoma · Lymphoma, Small Lymphocytic
United States, Argentina, Australia, Belgium, Brazil +13 more
CGM Use in Adults With Type 2 Diabetes on Basal InsulinActive Not Recruiting
NCT05944432NAUpdated Aug 21, 2026
Sponsor: Abbott Diabetes Care
Diabetes Mellitus, Type 2
United Kingdom
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightRecruiting
NCT07353931Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Osteoarthritis · Overweight or Obesity
United States, Argentina, Belgium, Brazil, Canada +9 more
Pediatric Long-Term Follow-up and Rollover StudyActive Not Recruiting
NCT03975829Phase 4Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Astrocytoma · Anaplastic Astrocytoma · Astrocytoma · Oligodendroglioma, Childhood
United States, Argentina, Australia, Belgium, Brazil +14 more
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.Recruiting
NCT07288489Phase 3Updated Aug 21, 2026
Sponsor: VarmX B.V.
Blood Loss, Surgical · Coagulation Disorder
United States, Australia, Bulgaria, France, Japan +2 more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting
NCT06632457Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Metabolic Dysfunction Associated Steatohepatitis
United States, Argentina, Australia, Austria, Belgium +31 more
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerActive Not Recruiting
NCT04360941Phase 1Updated Aug 21, 2026
Sponsor: Royal Marsden NHS Foundation Trust
Triple Negative Breast Cancer · Locally Advanced Breast Cancer · Recurrent Breast Cancer · Metastatic Breast Cancer
United Kingdom
Attachment Inhibitor Comparison in Heavily Treatment Experienced PatientsActive Not Recruiting
NCT02362503Phase 3Updated Aug 21, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Australia, Belgium, Brazil +20 more
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Recruiting
NCT05139017Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
DLBCL · Diffuse Large B-Cell Lymphoma
United States, Argentina, Australia, Brazil, Canada +21 more
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruiting
NCT06937086Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Ulcerative Colitis · Obesity or Overweight
United States, Austria, Belgium, Brazil, Bulgaria +18 more
Prevalence and Measurement of Delayed Gastric Emptying in Patients Receiving Extracorporeal Membrane OxygenationNot Yet Recruiting
NCT07779174N/AUpdated Aug 21, 2026
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Gastric Emptying · Delayed Gastric Emptying · Critical Illness · ExtraCorporeal Membrane Oxygenation (ECMO)
United Kingdom
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerRecruiting
NCT07213674Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Metastatic Castration-resistant Prostate Cancer
United States, Australia, Austria, Belgium, Canada +13 more
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use DisorderRecruiting
NCT07219966Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Alcohol Use Disorder
United States, Belgium, China, Germany, Japan +3 more
Skeletal Muscle Adaptations to Peptide-Supplemented Resistance Exercise TrainingRecruiting
NCT07773142NAUpdated Aug 21, 2026
Sponsor: University of Birmingham
Supplement · Resistance Training Adaptation
United Kingdom
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving HemodialysisRecruiting
NCT03969329Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Secondary Hyperparathyroidism
Belgium, Czechia, France, Germany, Greece +7 more
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Recruiting
NCT07513376Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Australia, Canada, France, Germany +11 more
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineRecruiting
NCT07018713Phase 3Updated Aug 21, 2026
Sponsor: Merz Therapeutics GmbH
Chronic Migraine
United States, Austria, Canada, Czechia, Denmark +8 more
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartRecruiting
NCT06935370Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Heart Failure
United States, Argentina, Belgium, Brazil, Bulgaria +24 more

Previous page Next page